The impact of calcitriol and estradiol on the SARS-CoV-2 biological activity: a molecular modeling approach

Mansouri et al., Scientific Reports, doi:10.1038/s41598-022-04778-y, Jan 2022

Source

PDF

All
Studies

Meta
Analysis

https://c19early.org/mansouri.html

Vitamin D for COVID-19

8th treatment shown to reduce risk in October 2020, now with p < 0.00000000001 from 126 studies, recognized in 18 countries.

Lower risk for mortality, ICU, hospitalization, progression, recovery, cases, and viral clearance.

No treatment is 100% effective. Protocols combine treatments.

5,800+ studies for 172 treatments. c19early.org

In Silico study predicting that calcitriol and estradiol disrupt the interaction between the SARS-CoV-2 spike protein and ACE2. Authors note that calcitriol may be more effective in the presence of estradiol.

25 preclinical studies support the efficacy of vitamin D for COVID-19:

9 In Silico studies1-9

13 In Vitro studies10-22

3 In Vivo animal studies14,18,23

Vitamin D has been identified by the European Food Safety Authority (EFSA) as having sufficient evidence for a causal relationship between intake and optimal immune system function24-27. Vitamin D inhibits SARS-CoV-2 replication in vitro14,21, mitigates lung inflammation, damage, and lethality in mice with an MHV-3 model for β-CoV respiratory infections14,21, reduces SARS-CoV-2 replication in nasal epithelial cells via increased type I interferon expression17, downregulates proinflammatory cytokines IL-1β and TNF-α in SARS-CoV-2 spike protein-stimulated cells13, attenuates nucleocapsid protein-induced hyperinflammation by inactivating the NLRP3 inflammasome through the VDR-BRCC3 signaling pathway18, may be neuroprotective by protecting the blood-brain barrier, reducing neuroinflammation, and via immunomodulatory effects28, may mitigate hyperinflammation and cytokine storm by upregulating TLR10 expression which downregulates proinflammatory cytokines10, downregulates ACE2 and TMPRSS2 in human trophoblasts and minimizes spike protein-induced inflammation16, may minimize cytokine storm by dampening excessive cytokine production1, minimizes platelet aggregation mediated by SARS-CoV-2 spike protein via inhibiting integrin αIIbβ3 outside-in signaling12, and improves regulatory immune cell levels and control of proinflammatory cytokines in severe COVID-1929. Calcifediol inhibits SARS-CoV-2 papain-like protease (PLpro), a critical enzyme for viral replication11. Symptomatic COVID-19 is associated with a lower frequency of natural killer (NK) cells and vitamin D has been shown to improve NK cell activity30,31.

Important missing comments or errors? Let us know.

1. Alzahrani, A., A new investigation into the molecular mechanism of cholecalciferol towards reducing cytokines storm, Octahedron Drug Research, doi:10.21608/odr.2024.308273.1043.ekb.eg, doi.org.

2. Haque et al., Exploring potential therapeutic candidates against COVID-19: a molecular docking study, Discover Molecules, doi:10.1007/s44345-024-00005-5.springer.com, doi.org.

3. Morales-Bayuelo et al., New findings on ligand series used as SARS-CoV-2 virus inhibitors within the frameworks of molecular docking, molecular quantum similarity and chemical reactivity indices, F1000Research, doi:10.12688/f1000research.123550.3.f1000research.com, doi.org.

4. Chellasamy et al., Docking and molecular dynamics studies of human ezrin protein with a modelled SARS-CoV-2 endodomain and their interaction with potential invasion inhibitors, Journal of King Saud University - Science, doi:10.1016/j.jksus.2022.102277.sciencedirect.com, doi.org.

5. Pandya et al., Unravelling Vitamin B12 as a potential inhibitor against SARS-CoV-2: A computational approach, Informatics in Medicine Unlocked, doi:10.1016/j.imu.2022.100951.sciencedirect.com, doi.org.

6. Mansouri et al., The impact of calcitriol and estradiol on the SARS-CoV-2 biological activity: a molecular modeling approach, Scientific Reports, doi:10.1038/s41598-022-04778-y.nature.com, doi.org.

7. Song et al., Vitamin D3 and its hydroxyderivatives as promising drugs against COVID-19: a computational study, Journal of Biomolecular Structure and Dynamics, doi:10.1080/07391102.2021.1964601.tandfonline.com, doi.org.

8. Qayyum et al., Vitamin D and lumisterol novel metabolites can inhibit SARS-CoV-2 replication machinery enzymes, Endocrinology and Metabolism, doi:10.1152/ajpendo.00174.2021.physiology.org, doi.org.

9. Al-Mazaideh et al., Vitamin D is a New Promising Inhibitor to the Main Protease (Mpro) of COVID-19 by Molecular Docking, Journal of Pharmaceutical Research International, doi:10.9734/jpri/2021/v33i29B31603.journaljpri.com, doi.org.

10. Knez et al., TLR10 overexpression modulates immune response in A549 lung epithelial cells challenged with SARS-CoV-2 S and N proteins, Frontiers in Immunology, doi:10.3389/fimmu.2024.1490478.frontiersin.org, doi.org.

11. Chen et al., In Vitro Characterization of Inhibition Function of Calcifediol to the Protease Activity of SARS-COV-2 PLpro, Journal of Medical Virology, doi:10.1002/jmv.70085.wiley.com, doi.org.

12. Wang et al., 1,25‐Dihydroxyvitamin D3 attenuates platelet aggregation potentiated by SARS‐CoV‐2 spike protein via inhibiting integrin αIIbβ3 outside‐in signaling, Cell Biochemistry and Function, doi:10.1002/cbf.4039.wiley.com, doi.org.

13. Alcalá-Santiago et al., Disentangling the Immunomodulatory Effects of Vitamin D on the SARS-CoV-2 Virus by In Vitro Approaches, The 14th European Nutrition Conference FENS 2023, doi:10.3390/proceedings2023091415.mdpi.com, doi.org.

14. Campolina-Silva et al., Dietary Vitamin D Mitigates Coronavirus-Induced Lung Inflammation and Damage in Mice, Viruses, doi:10.3390/v15122434.mdpi.com, doi.org.

15. Moatasim et al., Potent Antiviral Activity of Vitamin B12 against Severe Acute Respiratory Syndrome Coronavirus 2, Middle East Respiratory Syndrome Coronavirus, and Human Coronavirus 229E, Microorganisms, doi:10.3390/microorganisms11112777.mdpi.com, doi.org.

16. Vargas-Castro et al., Calcitriol prevents SARS-CoV spike-induced inflammation in human trophoblasts through downregulating ACE2 and TMPRSS2 expression, The Journal of Steroid Biochemistry and Molecular Biology, doi:10.1016/j.jsbmb.2024.106625.sciencedirect.com, doi.org.

17. Sposito et al., Age differential CD13 and interferon expression in airway epithelia affect SARS-CoV-2 infection - effects of vitamin D, Mucosal Immunology, doi:10.1016/j.mucimm.2023.08.002.nih.gov, doi.org.

18. Chen (B) et al., Vitamin D3 attenuates SARS‐CoV‐2 nucleocapsid protein‐caused hyperinflammation by inactivating the NLRP3 inflammasome through the VDR‐BRCC3 signaling pathway in vitro and in vivo, MedComm, doi:10.1002/mco2.318.wiley.com, doi.org.

19. Rybakovsky et al., Calcitriol modifies tight junctions, improves barrier function, and reduces TNF‐α‐induced barrier leak in the human lung‐derived epithelial cell culture model, 16HBE 14o‐, Physiological Reports, doi:10.14814/phy2.15592.wiley.com, doi.org.

20. DiGuilio et al., The multiphasic TNF-α-induced compromise of Calu-3 airway epithelial barrier function, Experimental Lung Research, doi:10.1080/01902148.2023.2193637.tandfonline.com, doi.org.

21. Pickard et al., Discovery of re-purposed drugs that slow SARS-CoV-2 replication in human cells, PLOS Pathogens, doi:10.1371/journal.ppat.1009840.plos.org, doi.org.

22. Mok et al., Calcitriol, the active form of vitamin D, is a promising candidate for COVID-19 prophylaxis, bioRxiv, doi:10.1101/2020.06.21.162396.biorxiv.org, doi.org.

23. Fernandes de Souza et al., Lung Inflammation Induced by Inactivated SARS-CoV-2 in C57BL/6 Female Mice Is Controlled by Intranasal Instillation of Vitamin D, Cells, doi:10.3390/cells12071092.mdpi.com, doi.org.

24. Galmés et al., Suboptimal Consumption of Relevant Immune System Micronutrients Is Associated with a Worse Impact of COVID-19 in Spanish Populations, Nutrients, doi:10.3390/nu14112254.mdpi.com, doi.org.

25. Galmés (B) et al., Current State of Evidence: Influence of Nutritional and Nutrigenetic Factors on Immunity in the COVID-19 Pandemic Framework, Nutrients, doi:10.3390/nu12092738.mdpi.com, doi.org.

26. EFSA, Scientific Opinion on the substantiation of a health claim related to vitamin D and contribution to the normal function of the immune system pursuant to Article 14 of Regulation (EC) No 1924/2006, EFSA Journal, doi:10.2903/j.efsa.2015.4096.europa.eu, doi.org.

27. EFSA (B), Scientific Opinion on the substantiation of health claims related to vitamin D and normal function of the immune system and inflammatory response (ID 154, 159), maintenance of normal muscle function (ID 155) and maintenance of normal cardiovascular function (ID 159) pursuant to Article 13(1) of Regulation (E, EFSA Journal, doi:10.2903/j.efsa.2010.1468.wiley.com, doi.org.

28. Gotelli et al., Understanding the immune-endocrine effects of vitamin D in SARS-CoV-2 infection: a role in protecting against neurodamage?, Neuroimmunomodulation, doi:10.1159/000533286.karger.com, doi.org.

29. Saheb Sharif-Askari et al., Increased blood immune regulatory cells in severe COVID-19 with autoantibodies to type I interferons, Scientific Reports, doi:10.1038/s41598-023-43675-w.nature.com, doi.org.

30. Graydon et al., High baseline frequencies of natural killer cells are associated with asymptomatic SARS-CoV-2 infection, Current Research in Immunology, doi:10.1016/j.crimmu.2023.100064.sciencedirect.com, doi.org.

31. Oh et al., Vitamin D and Exercise Are Major Determinants of Natural Killer Cell Activity, Which Is Age- and Gender-Specific, Frontiers in Immunology, doi:10.3389/fimmu.2021.594356.frontiersin.org, doi.org.

Mansouri et al., 13 Jan 2022, peer-reviewed, 5 authors. Contact: kowsarzar@yahoo.com, akiomiya@obihiro.ac.jp.

In Silico studies are an important part of preclinical research, however results may be very different in vivo.

This Paper Vitamin D All

The impact of calcitriol and estradiol on the SARS-CoV-2 biological activity: a molecular modeling approach

Alireza Mansouri, Rasoul Kowsar, Mostafa Zakariazadeh, Hassan Hakimi, Akio Miyamoto

Scientific Reports, doi:10.1038/s41598-022-04778-y

The novel coronavirus disease (COVID-19) is currently a big concern around the world. Recent reports show that the disease severity and mortality of COVID-19 infected patients may vary from gender to gender with a very high risk of death for seniors. In addition, some steroid structures have been reported to affect coronavirus, SARS-CoV-2, function and activity. The entry of SARS-CoV-2 into host cells depends on the binding of coronavirus spike protein to angiotensin converting enzyme-2 (ACE2). Viral main protease is essential for the replication of SARS-CoV-2. It was hypothesized that steroid molecules (e.g., estradiol, progesterone, testosterone, dexamethasone, hydrocortisone, prednisone and calcitriol) could occupy the active site of the protease and could alter the interaction of spike protein with ACE2. Computational data showed that estradiol interacted more strongly with the main protease active site. In the presence of calcitriol, the binding energy of the spike protein to ACE2 was increased, and transferring Apo to Locked S conformer of spike trimer was facilitated. Together, the interaction between spike protein and ACE2 can be disrupted by calcitriol. Potential use of estradiol and calcitriol to reduce virus invasion and replication needs clinical investigation. The novel coronavirus disease (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first recognized in the Hubei Province of China in December 2019 and has been reported as a very widespread disease with people-to-people transmission. Clinical evidence suggests that women are more resilient than men in terms of COVID-19 [1] [2] [3] [4] [5] . In the previous study, the critical factors involved in increasing the mortality and severity of COVID-19 in patients were investigated and higher disease severity and mortality were found in male patients 2 . It has been reported that 12.8% of 86 men died and 75.6% recovered, while 7.3% of 82 females died and 86.6% recovered 6 . In addition, the reports showed a relatively low risk of incidence in children but a very high risk of death in seniors 7 . Elderly patients diagnosed with COVID-19 aged 60 or older 8 had higher clinical signs, higher severity and longer periods of illness 9 . Sex steroid hormones are the primary cause of female and male differences. Testosterone (T) known as the predominant sex steroid hormone in males plays an essential role in sexual and reproductive development. In women, the predominant sex steroid hormones progesterone (P4) and estradiol (E2) are produced by ovaries. With respect to the menstrual cycle, the concentration of E2 reaches the highest level just before ovulation (during the follicular or proliferative phase) and then decreases shortly afterwards (during the luteal or secretory phase). P4 is released at peak level during the luteal phase, and then drops before the next menstrual period. Decreases in menopausal-associated ovarian hormones have been..

Author contributions Conceptualization: R.K., A.M.; Funding acquisition: R.K., A.M.; Investigation: Al.M., R.K., M.Z.; Methodology: Al.M., R.K., M.Z.; Software and Visualization: Al.M., M.Z.; Supervision: A.M., R.K.; Validation: Al.M., R.K., H.H., M.Z.; Writing-original draft: Al.M., R.K., M.Z., H.H.; Writing-review and editing: Al.M., R.K., M.Z., H.H., A.M. Competing interests The authors declare no competing interests. Additional information Supplementary Information The online version contains supplementary material available at https:// doi. org/ 10. 1038/ s41598-022-04778-y. Correspondence and requests for materials should be addressed to R.K. or A.M. Reprints and permissions information is available at www.nature.com/reprints. Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

Abraham, Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1, J. Exp. Med

Abraham, GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers, SoftwareX

Aguilar-Pineda, Structural and functional analysis of female sex hormones against SARS-Cov2 cell entry, bioRxiv

Aksoy, The effect of progesterone on systemic inflammation and oxidative stress in the rat model of sepsis, Indian J. Pharmacol

Asadi, Tabatabaei, Safinejad, Mohammadi, New corona virus (COVID-19) management in pregnancy and childbirth, Arch. Clin. Infect. Dis

Baker, Sept, Joseph, Holst, Mccammon, Electrostatics of nanosystems: Application to microtubules and the ribosome, Proc. Natl. Acad. Sci

Barzegar, Mansouri, Azamat, Molecular dynamics simulation of non-covalent single-walled carbon nanotube functionalization with surfactant peptides, J. Mol. Graph. Model

Barzegar, Naghizadeh, Zakariazadeh, Azamat, Molecular dynamics simulation study of the HIV-1 protease inhibit ion using fullerene and new fullerene derivatives of carbon nanostructures, Mini Rev. Med. Chem

Bello, Prediction of potential inhibitors of the dimeric SARS-CoV2 main proteinase through the MM/GBSA approach, J. Mol. Graph. Model

Bianchi, The anti-inflammatory effects of testosterone, J. Endocr. Soc

Bjelkmar, Larsson, Cuendet, Hess, Lindahl, Implementation of the CHARMM Force Field in GROMACS: Analysis of protein stability effects from correction maps, virtual interaction sites, and water models, J. Chem. Theory Comput

Bodner-Adler, Association of endogenous circulating sex steroids and condition-specific quality of life domains in postmenopausal women with pelvic floor disorders, Arch. Gynecol. Obstet

Brooks, CHARMM: The biomolecular simulation program, J. Comput. Chem

Conti, Younes, Coronavirus COV-19/SARS-CoV-2 affects women less than men: Clinical response to viral infection, J. Biol. Regul. Homeost. Agents

Cooper, Hausman, The Cell: A Molecular Approach

Corral, GLUCOCOVID: A controlled trial of methylprednisolone in adults hospitalized with COVID-19 pneumonia

Da Silva, Dos Santos, Aqueous solution interactions with sex hormone-binding globulin and estradiol: A theoretical investigation, J. Biol. Phys

Díaz-Villanueva, Díaz-Molina, García-González, Protein folding and mechanisms of proteostasis, Int. J. Mol. Sci

Elmezayen, Al-Obaidi, Şahin, Yelekçi, Drug repurposing for coronavirus (COVID-19): In silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes, J. Biomol. Struct. Dyn

Freedman, Quality of life and menopause: The role of estrogen, J. Womens Health

Frishman, Argos, Knowledge-based protein secondary structure assignment, Proteins

Fährrolfes, ProteinsPlus: A web portal for structure analysis of macromolecules, Nucleic Acids Res

Grant, Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths, Nutrients

Graziano, Mcgrath, Yang, Mangel, SARS CoV main proteinase: The monomer−dimer equilibrium dissociation constant, Biochemistry

Guenther, Inhibition of SARS-CoV-2 main protease by allosteric drug-binding, bioRxiv

Günther, X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease, Science

Halgren, Identifying and characterizing binding sites and assessing druggability, J. Chem. Inf. Model

Hess, P-LINCS: A parallel linear constraint solver for molecular simulation, J. Chem. Theory Comput

Hopkins, Groom, The druggable genome, Nat. Rev. Drug Discov

Hosseini-Kharat, In vitro and in vivo antiproliferative activity of organo-nickel SCS-pincer complexes on estrogen responsive MCF7 and MC4L2 breast cancer cells. Effects of amine fragment substitutions on BSA binding and cytotoxicity, Dalton Trans

Ilie, Stefanescu, Smith, The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality, Aging Clin. Exp. Res

Jeronimo, Methylprednisolone as adjunctive therapy for patients hospitalized with COVID-19 (Metcovid): A randomised, double-blind, phase IIb, placebo-controlled trial, Clin. Infect. Dis

Jin, Gender differences in patients with COVID-19: focus on severity and mortality, Front. Public Health

Jin, Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur, Nat. Struct. Mol. Biol

Jin, Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors, Nature

Khan, Zia, Ashraf, Uddin, Ul-Haq, Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach, J. Biomol. Struct. Dyn

Klein, Flanagan, Sex differences in immune responses, Nat. Rev. Immunol

Kolilekas, Can steroids reverse the severe COVID-19 induced "cytokine storm"?, J. Med. Virol

Kowsar, Evidence for a novel, local acute-phase response in the bovine oviduct: Progesterone and lipopolysaccharide upregulate alpha 1-acid-glycoprotein expression in epithelial cells in vitro, Mol. Reprod. Dev

Kowsar, Keshtegar, Miyamoto, Understanding the hidden relations between pro-and anti-inflammatory cytokine genes in bovine oviduct epithelium using a multilayer response surface method, Sci. Rep

Kumari, Kumar, Lynn, g_mmpbsa-A GROMACS tool for high-throughput MM-PBSA calculations, J. Chem. Inf. Model

Lan, Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor, Nature

Lee, CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM simulations using the CHARMM36 additive force field, J. Chem. Theory Comput

Leung, Risk factors for predicting mortality in elderly patients with COVID-19: A review of clinical data in China, Mech. Ageing Dev

Li, Age-dependent risks of incidence and mortality of COVID-19 in Hubei Province and other parts of China, Front. Med

Li, Li, Sex-dependent immune response and lethality of COVID-19, Stem Cell Res

Liu, Association between age and clinical characteristics and outcomes of COVID-19, Eur. Respir. J

Luan, Lu, Gao, Zhang, A potential inhibitory role for integrin in the receptor targeting of SARS-CoV-2, J. Infect

Magri, β-estradiol inhibits hepatitis C virus mainly by interference with the release phase of its life cycle, Liver Int

Mahase, Covid-19: Hydrocortisone can be used as alternative to dexamethasone, review finds, BMJ (Clin. Res. Ed.)

Mansouri, Mahnam, Designing new surfactant peptides for binding to carbon nanotubes via computational approaches, J. Mol. Graph. Model

Meng, Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China: A retrospective study of 168 severe patients, PLoS Pathog

Mercola, Grant, Wagner, Evidence regarding vitamin D and risk of COVID-19 and its severity, Nutrients

Murrell, Murase, The dermatologist's perspective: Why is COVID-19 mortality lower in females than males?, Int. J. Womens Dermatol

Musba, Tanra, Yusuf, Ahmad, The effect of dexamethasone on the dynamics of inflammation, cortisol and analgesia in lower limb surgery, J. Pain Relief

Oren, Fleishman, Kessel, Ben-Tal, Free diffusion of steroid hormones across biomembranes: a simplex search with implicit solvent model calculations, Biophys. J

Pozzilli, Lenzi, Commentary: Testosterone, a key hormone in the context of COVID-19 pandemic, Metabol. Clin. Exp

Pérot, Sperandio, Miteva, Camproux, Villoutreix, Druggable pockets and binding site centric chemical space: A paradigm shift in drug discovery, Drug Discov. Today

Ravindranath, Forli, Goodsell, Olson, Sanner et al., Advances in protein-ligand docking with explicitly specified binding site flexibility, PLoS Comput. Biol

Russell, Millar, Baillie, Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury, Lancet

Scully, Haverfield, Ursin, Tannenbaum, Klein, Considering how biological sex impacts immune responses and COVID-19 outcomes, Nat. Rev. Immunol

Segars, Prior and novel coronaviruses, coronavirus disease 2019 (COVID-19), and human reproduction: What is known?, Fertil. Steril

Sharma, Volgman, Michos, Sex differences in mortality from COVID-19 pandemic: Are men vulnerable and women protected?, JACC Case Rep

Shoemark, Molecular simulations suggest vitamins, retinoids and steroids as ligands of the free fatty acid pocket of the SARS-CoV-2 spike protein, Angew. Chem

So, Ro, Murakami, Imai, Jinta, High-dose, short-term corticosteroids for ARDS caused by COVID-19: A case series, Respirol. Case Rep

Tetko, Tanchuk, Application of associative neural networks for prediction of lipophilicity in ALOGPS 2.1 program, J. Chem. Inform. Comput. Sci

Toelzer, Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein, Science

Trott, Olson, Vina, Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading, J. Comput. Chem, doi:10.1002/jcc.21334

Van Zundert, The HADDOCK2.2 web server: User-friendly integrative modeling of biomolecular complexes, J. Mol. Biol

Volkamer, Kuhn, Rippmann, Rarey, DoGSiteScorer: A web server for automatic binding site prediction, analysis and druggability assessment, Bioinformatics

Wallace, Laskowski, Thornton, LIGPLOT: A program to generate schematic diagrams of protein-ligand interactions, Protein Eng

Wang, Structural and functional basis of SARS-CoV-2 entry by using human ACE2, Cell

Ye, Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: A systematic review and meta-analysis, CMAJ

Yuki, Fujiogi, Koutsogiannaki, COVID-19 pathophysiology: A review, Clin Immunol

Zhang, Potent noncovalent inhibitors of the main protease of SARS-CoV-2 from molecular sculpting of the drug perampanel guided by free energy perturbation calculations, ACS Cent. Sci

Zhao, COVID-19 and gender-specific difference: Analysis of public surveillance data in Hong Kong and Shenzhen, China, from, Infect. Control Hosp. Epidemiol

Zhao, The time-varying serial interval of the coronavirus disease (COVID-19) and its gender-specific difference: A datadriven analysis using public surveillance data in Hong Kong and Shenzhen, China from, Infect. Control Hosp. Epidemiol

Zoete, Cuendet, Grosdidier, Michielin, SwissParam: A fast force field generation tool for small organic molecules, J. Comput. Chem

DOI record: { "DOI": "10.1038/s41598-022-04778-y", "ISSN": [ "2045-2322" ], "URL": "http://dx.doi.org/10.1038/s41598-022-04778-y", "abstract": "AbstractThe novel coronavirus disease (COVID-19) is currently a big concern around the world. Recent reports show that the disease severity and mortality of COVID-19 infected patients may vary from gender to gender with a very high risk of death for seniors. In addition, some steroid structures have been reported to affect coronavirus, SARS-CoV-2, function and activity. The entry of SARS-CoV-2 into host cells depends on the binding of coronavirus spike protein to angiotensin converting enzyme-2 (ACE2). Viral main protease is essential for the replication of SARS-CoV-2. It was hypothesized that steroid molecules (e.g., estradiol, progesterone, testosterone, dexamethasone, hydrocortisone, prednisone and calcitriol) could occupy the active site of the protease and could alter the interaction of spike protein with ACE2. Computational data showed that estradiol interacted more strongly with the main protease active site. In the presence of calcitriol, the binding energy of the spike protein to ACE2 was increased, and transferring Apo to Locked S conformer of spike trimer was facilitated. Together, the interaction between spike protein and ACE2 can be disrupted by calcitriol. Potential use of estradiol and calcitriol to reduce virus invasion and replication needs clinical investigation.", "alternative-id": [ "4778" ], "article-number": "717", "assertion": [ { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "Received", "name": "received", "order": 1, "value": "6 July 2021" }, { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "Accepted", "name": "accepted", "order": 2, "value": "30 December 2021" }, { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "First Online", "name": "first_online", "order": 3, "value": "13 January 2022" }, { "group": { "label": "Competing interests", "name": "EthicsHeading" }, "name": "Ethics", "order": 1, "value": "The authors declare no competing interests." } ], "author": [ { "affiliation": [], "family": "Mansouri", "given": "Alireza", "sequence": "first" }, { "affiliation": [], "family": "Kowsar", "given": "Rasoul", "sequence": "additional" }, { "affiliation": [], "family": "Zakariazadeh", "given": "Mostafa", "sequence": "additional" }, { "affiliation": [], "family": "Hakimi", "given": "Hassan", "sequence": "additional" }, { "affiliation": [], "family": "Miyamoto", "given": "Akio", "sequence": "additional" } ], "container-title": "Scientific Reports", "container-title-short": "Sci Rep", "content-domain": { "crossmark-restriction": false, "domain": [ "link.springer.com" ] }, "created": { "date-parts": [ [ 2022, 1, 13 ] ], "date-time": "2022-01-13T11:03:33Z", "timestamp": 1642071813000 }, "deposited": { "date-parts": [ [ 2022, 11, 24 ] ], "date-time": "2022-11-24T21:06:37Z", "timestamp": 1669323997000 }, "indexed": { "date-parts": [ [ 2023, 1, 9 ] ], "date-time": "2023-01-09T10:16:39Z", "timestamp": 1673259399284 }, "is-referenced-by-count": 6, "issue": "1", "issued": { "date-parts": [ [ 2022, 1, 13 ] ] }, "journal-issue": { "issue": "1", "published-online": { "date-parts": [ [ 2022, 12 ] ] } }, "language": "en", "license": [ { "URL": "https://creativecommons.org/licenses/by/4.0", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2022, 1, 13 ] ], "date-time": "2022-01-13T00:00:00Z", "timestamp": 1642032000000 } }, { "URL": "https://creativecommons.org/licenses/by/4.0", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2022, 1, 13 ] ], "date-time": "2022-01-13T00:00:00Z", "timestamp": 1642032000000 } } ], "link": [ { "URL": "https://www.nature.com/articles/s41598-022-04778-y.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://www.nature.com/articles/s41598-022-04778-y", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://www.nature.com/articles/s41598-022-04778-y.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "297", "original-title": [], "prefix": "10.1038", "published": { "date-parts": [ [ 2022, 1, 13 ] ] }, "published-online": { "date-parts": [ [ 2022, 1, 13 ] ] }, "publisher": "Springer Science and Business Media LLC", "reference": [ { "author": "P Conti", "first-page": "339", "journal-title": "J. Biol. Regul. Homeost. Agents", "key": "4778_CR1", "unstructured": "Conti, P. & Younes, A. Coronavirus COV-19/SARS-CoV-2 affects women less than men: Clinical response to viral infection. J. Biol. Regul. Homeost. Agents 34, 339–343 (2020).", "volume": "34", "year": "2020" }, { "DOI": "10.3389/fpubh.2020.00152", "author": "JM Jin", "doi-asserted-by": "crossref", "first-page": "152", "journal-title": "Front. Public Health", "key": "4778_CR2", "unstructured": "Jin, J. M. et al. Gender differences in patients with COVID-19: focus on severity and mortality. Front. Public Health 8, 152 (2020).", "volume": "8", "year": "2020" }, { "DOI": "10.1016/j.jaccas.2020.04.027", "author": "G Sharma", "doi-asserted-by": "crossref", "first-page": "1407", "journal-title": "JACC Case Rep.", "key": "4778_CR3", "unstructured": "Sharma, G., Volgman, A. S. & Michos, E. D. Sex differences in mortality from COVID-19 pandemic: Are men vulnerable and women protected?. JACC Case Rep. 2, 1407–1410 (2020).", "volume": "2", "year": "2020" }, { "DOI": "10.1017/ice.2020.64", "author": "S Zhao", "doi-asserted-by": "crossref", "first-page": "750", "journal-title": "Infect. Control Hosp. Epidemiol.", "key": "4778_CR4", "unstructured": "Zhao, S. et al. COVID-19 and gender-specific difference: Analysis of public surveillance data in Hong Kong and Shenzhen, China, from January 10 to February 15, 2020. Infect. Control Hosp. Epidemiol. 41, 750–751 (2020).", "volume": "41", "year": "2020" }, { "DOI": "10.1016/j.ijwd.2020.04.011", "author": "DF Murrell", "doi-asserted-by": "crossref", "first-page": "152", "journal-title": "Int. J. Womens Dermatol.", "key": "4778_CR5", "unstructured": "Murrell, D. F. & Murase, J. E. The dermatologist’s perspective: Why is COVID-19 mortality lower in females than males?. Int. J. Womens Dermatol. 6, 152–153 (2020).", "volume": "6", "year": "2020" }, { "DOI": "10.1371/journal.ppat.1008520", "author": "Y Meng", "doi-asserted-by": "crossref", "first-page": "e1008520", "journal-title": "PLoS Pathog.", "key": "4778_CR6", "unstructured": "Meng, Y. et al. Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China: A retrospective study of 168 severe patients. PLoS Pathog. 16, e1008520 (2020).", "volume": "16", "year": "2020" }, { "DOI": "10.3389/fmed.2020.00190", "author": "H Li", "doi-asserted-by": "crossref", "first-page": "190", "journal-title": "Front. Med.", "key": "4778_CR7", "unstructured": "Li, H. et al. Age-dependent risks of incidence and mortality of COVID-19 in Hubei Province and other parts of China. Front. Med. 7, 190 (2020).", "volume": "7", "year": "2020" }, { "DOI": "10.1016/j.mad.2020.111255", "author": "C Leung", "doi-asserted-by": "crossref", "first-page": "111255", "journal-title": "Mech. Ageing Dev.", "key": "4778_CR8", "unstructured": "Leung, C. Risk factors for predicting mortality in elderly patients with COVID-19: A review of clinical data in China. Mech. Ageing Dev. 188, 111255 (2020).", "volume": "188", "year": "2020" }, { "DOI": "10.1183/13993003.01112-2020", "doi-asserted-by": "crossref", "key": "4778_CR9", "unstructured": "Liu, Y. et al. Association between age and clinical characteristics and outcomes of COVID-19. Eur. Respir. J. 55 (2020)." }, { "DOI": "10.1089/15409990260363661", "author": "MA Freedman", "doi-asserted-by": "crossref", "first-page": "703", "issue": "11", "journal-title": "J. Womens Health", "key": "4778_CR10", "unstructured": "Freedman, M. A. Quality of life and menopause: The role of estrogen. J. Womens Health 2002(11), 703–718 (2002).", "volume": "2002", "year": "2002" }, { "DOI": "10.1007/s00404-018-4650-7", "author": "B Bodner-Adler", "doi-asserted-by": "crossref", "first-page": "725", "journal-title": "Arch. Gynecol. Obstet.", "key": "4778_CR11", "unstructured": "Bodner-Adler, B. et al. Association of endogenous circulating sex steroids and condition-specific quality of life domains in postmenopausal women with pelvic floor disorders. Arch. Gynecol. Obstet. 297, 725–730 (2018).", "volume": "297", "year": "2018" }, { "DOI": "10.1002/mrd.22355", "author": "R Kowsar", "doi-asserted-by": "crossref", "first-page": "861", "journal-title": "Mol. Reprod. Dev.", "key": "4778_CR12", "unstructured": "Kowsar, R. et al. Evidence for a novel, local acute-phase response in the bovine oviduct: Progesterone and lipopolysaccharide up-regulate alpha 1-acid-glycoprotein expression in epithelial cells in vitro. Mol. Reprod. Dev. 81, 861–870 (2014).", "volume": "81", "year": "2014" }, { "DOI": "10.1210/js.2018-00186", "author": "VE Bianchi", "doi-asserted-by": "crossref", "first-page": "91", "journal-title": "J. Endocr. Soc.", "key": "4778_CR13", "unstructured": "Bianchi, V. E. The anti-inflammatory effects of testosterone. J. Endocr. Soc. 3, 91–107 (2019).", "volume": "3", "year": "2019" }, { "DOI": "10.4103/0253-7613.144922", "author": "AN Aksoy", "doi-asserted-by": "crossref", "first-page": "622", "journal-title": "Indian J. Pharmacol.", "key": "4778_CR14", "unstructured": "Aksoy, A. N. et al. The effect of progesterone on systemic inflammation and oxidative stress in the rat model of sepsis. Indian J. Pharmacol. 46, 622–626 (2014).", "volume": "46", "year": "2014" }, { "DOI": "10.1084/jem.20060336", "author": "SM Abraham", "doi-asserted-by": "crossref", "first-page": "1883", "journal-title": "J. Exp. Med.", "key": "4778_CR15", "unstructured": "Abraham, S. M. et al. Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1. J. Exp. Med. 203, 1883–1889 (2006).", "volume": "203", "year": "2006" }, { "author": "A Musba", "first-page": "1", "journal-title": "J. Pain Relief", "key": "4778_CR16", "unstructured": "Musba, A., Tanra, H., Yusuf, I. & Ahmad, R. The effect of dexamethasone on the dynamics of inflammation, cortisol and analgesia in lower limb surgery. J. Pain Relief 4, 1–6 (2015).", "volume": "4", "year": "2015" }, { "DOI": "10.1503/cmaj.200645", "author": "Z Ye", "doi-asserted-by": "crossref", "first-page": "E756", "journal-title": "CMAJ", "key": "4778_CR17", "unstructured": "Ye, Z. et al. Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: A systematic review and meta-analysis. CMAJ 192, E756–E767 (2020).", "volume": "192", "year": "2020" }, { "author": "E Mahase", "first-page": "m3472", "journal-title": "BMJ (Clin. Res. Ed.)", "key": "4778_CR18", "unstructured": "Mahase, E. Covid-19: Hydrocortisone can be used as alternative to dexamethasone, review finds. BMJ (Clin. Res. Ed.) 370, m3472 (2020).", "volume": "370", "year": "2020" }, { "key": "4778_CR19", "unstructured": "Corral, L. et al. GLUCOCOVID: A controlled trial of methylprednisolone in adults hospitalized with COVID-19 pneumonia. MedRxiv (2020)." }, { "key": "4778_CR20", "unstructured": "Jeronimo, C. M. P. et al. Methylprednisolone as adjunctive therapy for patients hospitalized with COVID-19 (Metcovid): A randomised, double-blind, phase IIb, placebo-controlled trial. Clin. Infect. Dis. (2020)." }, { "key": "4778_CR21", "unstructured": "World Health Organization. Corticosteroids for covid-19: Living guidance. 2 Sep 2020. https://www.who.int/publications/i/item/WHO-2019-nCoV-Corticosteroids-2020.1. (2020)." }, { "key": "4778_CR22", "unstructured": "National Institutes of Health (NIH). COVID-19 treatment guidelines https://www.covid19treatmentguidelines.nih.gov/immune-based-therapy/immunomodulators/corticosteroids/. (2020)." }, { "DOI": "10.1007/s40520-020-01570-8", "author": "PC Ilie", "doi-asserted-by": "crossref", "first-page": "1195", "journal-title": "Aging Clin. Exp. Res.", "key": "4778_CR23", "unstructured": "Ilie, P. C., Stefanescu, S. & Smith, L. The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. Aging Clin. Exp. Res. 32, 1195–1198 (2020).", "volume": "32", "year": "2020" }, { "DOI": "10.3390/nu12040988", "author": "WB Grant", "doi-asserted-by": "crossref", "first-page": "988", "journal-title": "Nutrients", "key": "4778_CR24", "unstructured": "Grant, W. B. et al. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients 12, 988 (2020).", "volume": "12", "year": "2020" }, { "DOI": "10.3390/nu12113361", "author": "J Mercola", "doi-asserted-by": "crossref", "first-page": "3361", "journal-title": "Nutrients", "key": "4778_CR25", "unstructured": "Mercola, J., Grant, W. B. & Wagner, C. L. Evidence regarding vitamin D and risk of COVID-19 and its severity. Nutrients 12, 3361 (2020).", "volume": "12", "year": "2020" }, { "DOI": "10.1529/biophysj.103.035527", "author": "I Oren", "doi-asserted-by": "crossref", "first-page": "768", "journal-title": "Biophys. J.", "key": "4778_CR26", "unstructured": "Oren, I., Fleishman, S. J., Kessel, A. & Ben-Tal, N. Free diffusion of steroid hormones across biomembranes: a simplex search with implicit solvent model calculations. Biophys. J. 87, 768–779 (2004).", "volume": "87", "year": "2004" }, { "author": "GM Cooper", "key": "4778_CR27", "unstructured": "Cooper, G. M. & Hausman, R. E. The Cell: A Molecular Approach (Oxford University Press, Oxford, 2018).", "volume-title": "The Cell: A Molecular Approach", "year": "2018" }, { "DOI": "10.1007/s10867-018-9505-8", "author": "AJ da Silva", "doi-asserted-by": "crossref", "first-page": "539", "journal-title": "J. Biol. Phys.", "key": "4778_CR28", "unstructured": "da Silva, A. J. & Dos Santos, E. S. Aqueous solution interactions with sex hormone-binding globulin and estradiol: A theoretical investigation. J. Biol. Phys. 44, 539–556 (2018).", "volume": "44", "year": "2018" }, { "DOI": "10.1016/j.jinf.2020.03.046", "author": "J Luan", "doi-asserted-by": "crossref", "first-page": "318", "journal-title": "J. Infect.", "key": "4778_CR29", "unstructured": "Luan, J., Lu, Y., Gao, S. & Zhang, L. A potential inhibitory role for integrin in the receptor targeting of SARS-CoV-2. J. Infect. 81, 318–356 (2020).", "volume": "81", "year": "2020" }, { "DOI": "10.1016/j.cell.2020.03.045", "author": "Q Wang", "doi-asserted-by": "crossref", "first-page": "894", "journal-title": "Cell", "key": "4778_CR30", "unstructured": "Wang, Q. et al. Structural and functional basis of SARS-CoV-2 entry by using human ACE2. Cell 181, 894-904.e899 (2020).", "volume": "181", "year": "2020" }, { "DOI": "10.1038/s41586-020-2180-5", "author": "J Lan", "doi-asserted-by": "crossref", "first-page": "215", "journal-title": "Nature", "key": "4778_CR31", "unstructured": "Lan, J. et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581, 215–220 (2020).", "volume": "581", "year": "2020" }, { "DOI": "10.1016/j.metabol.2020.154252", "author": "P Pozzilli", "doi-asserted-by": "crossref", "first-page": "154252", "journal-title": "Metabol. Clin. Exp.", "key": "4778_CR32", "unstructured": "Pozzilli, P. & Lenzi, A. Commentary: Testosterone, a key hormone in the context of COVID-19 pandemic. Metabol. Clin. Exp. 108, 154252 (2020).", "volume": "108", "year": "2020" }, { "DOI": "10.1016/j.fertnstert.2020.04.025", "author": "J Segars", "doi-asserted-by": "crossref", "first-page": "1140", "journal-title": "Fertil. Steril.", "key": "4778_CR33", "unstructured": "Segars, J. et al. Prior and novel coronaviruses, coronavirus disease 2019 (COVID-19), and human reproduction: What is known?. Fertil. Steril. 113, 1140–1149 (2020).", "volume": "113", "year": "2020" }, { "DOI": "10.1002/ange.202015639", "author": "DK Shoemark", "doi-asserted-by": "crossref", "first-page": "7174", "journal-title": "Angew. Chem.", "key": "4778_CR34", "unstructured": "Shoemark, D. K. et al. Molecular simulations suggest vitamins, retinoids and steroids as ligands of the free fatty acid pocket of the SARS-CoV-2 spike protein. Angew. Chem. 133, 7174–7186 (2021).", "volume": "133", "year": "2021" }, { "DOI": "10.1126/science.abd3255", "author": "C Toelzer", "doi-asserted-by": "crossref", "first-page": "725", "journal-title": "Science", "key": "4778_CR35", "unstructured": "Toelzer, C. et al. Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein. Science 370, 725–730 (2020).", "volume": "370", "year": "2020" }, { "author": "AD Elmezayen", "first-page": "1", "journal-title": "J. Biomol. Struct. Dyn.", "key": "4778_CR36", "unstructured": "Elmezayen, A. D., Al-Obaidi, A., Şahin, A. T. & Yelekçi, K. Drug repurposing for coronavirus (COVID-19): In silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes. J. Biomol. Struct. Dyn. 39, 1–13 (2020).", "volume": "39", "year": "2020" }, { "DOI": "10.1038/s41586-020-2223-y", "author": "Z Jin", "doi-asserted-by": "crossref", "first-page": "289", "journal-title": "Nature", "key": "4778_CR37", "unstructured": "Jin, Z. et al. Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors. Nature 582, 289–293 (2020).", "volume": "582", "year": "2020" }, { "DOI": "10.1038/s41594-020-0440-6", "author": "Z Jin", "doi-asserted-by": "crossref", "first-page": "529", "journal-title": "Nat. Struct. Mol. Biol.", "key": "4778_CR38", "unstructured": "Jin, Z. et al. Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur. Nat. Struct. Mol. Biol. 27, 529–532 (2020).", "volume": "27", "year": "2020" }, { "author": "SA Khan", "first-page": "1", "journal-title": "J. Biomol. Struct. Dyn.", "key": "4778_CR39", "unstructured": "Khan, S. A., Zia, K., Ashraf, S., Uddin, R. & Ul-Haq, Z. Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach. J. Biomol. Struct. Dyn. 39, 1–10 (2020).", "volume": "39", "year": "2020" }, { "DOI": "10.1021/bi061746y", "author": "V Graziano", "doi-asserted-by": "crossref", "first-page": "14632", "journal-title": "Biochemistry", "key": "4778_CR40", "unstructured": "Graziano, V., McGrath, W. J., Yang, L. & Mangel, W. F. SARS CoV main proteinase: The monomer−dimer equilibrium dissociation constant. Biochemistry 45, 14632–14641 (2006).", "volume": "45", "year": "2006" }, { "DOI": "10.1016/j.jmgm.2020.107762", "author": "M Bello", "doi-asserted-by": "crossref", "first-page": "107762", "journal-title": "J. Mol. Graph. Model", "key": "4778_CR41", "unstructured": "Bello, M. Prediction of potential inhibitors of the dimeric SARS-CoV2 main proteinase through the MM/GBSA approach. J. Mol. Graph. Model 101, 107762 (2020).", "volume": "101", "year": "2020" }, { "DOI": "10.1126/science.abf7945", "author": "S Günther", "doi-asserted-by": "crossref", "first-page": "642", "journal-title": "Science", "key": "4778_CR42", "unstructured": "Günther, S. et al. X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease. Science 372, 642–646 (2021).", "volume": "372", "year": "2021" }, { "key": "4778_CR43", "unstructured": "Guenther, S. et al. Inhibition of SARS-CoV-2 main protease by allosteric drug-binding. bioRxiv (2020)." }, { "DOI": "10.1016/j.jmgm.2017.02.016", "author": "A Mansouri", "doi-asserted-by": "crossref", "first-page": "61", "journal-title": "J. Mol. Graph. Model.", "key": "4778_CR44", "unstructured": "Mansouri, A. & Mahnam, K. Designing new surfactant peptides for binding to carbon nanotubes via computational approaches. J. Mol. Graph. Model. 74, 61–72 (2017).", "volume": "74", "year": "2017" }, { "DOI": "10.1016/j.jmgm.2016.01.003", "author": "A Barzegar", "doi-asserted-by": "crossref", "first-page": "75", "journal-title": "J. Mol. Graph. Model.", "key": "4778_CR45", "unstructured": "Barzegar, A., Mansouri, A. & Azamat, J. Molecular dynamics simulation of non-covalent single-walled carbon nanotube functionalization with surfactant peptides. J. Mol. Graph. Model. 64, 75–84 (2016).", "volume": "64", "year": "2016" }, { "DOI": "10.1039/C8DT03079K", "author": "M Hosseini-Kharat", "doi-asserted-by": "crossref", "first-page": "16944", "journal-title": "Dalton Trans.", "key": "4778_CR46", "unstructured": "Hosseini-Kharat, M. et al. In vitro and in vivo antiproliferative activity of organo-nickel SCS-pincer complexes on estrogen responsive MCF7 and MC4L2 breast cancer cells. Effects of amine fragment substitutions on BSA binding and cytotoxicity. Dalton Trans. 47, 16944–16957 (2018).", "volume": "47", "year": "2018" }, { "DOI": "10.3390/ijms160817193", "author": "JF Díaz-Villanueva", "doi-asserted-by": "crossref", "first-page": "17193", "journal-title": "Int. J. Mol. Sci.", "key": "4778_CR47", "unstructured": "Díaz-Villanueva, J. F., Díaz-Molina, R. & García-González, V. Protein folding and mechanisms of proteostasis. Int. J. Mol. Sci. 16, 17193–17230 (2015).", "volume": "16", "year": "2015" }, { "DOI": "10.1016/j.clim.2020.108427", "author": "K Yuki", "doi-asserted-by": "crossref", "first-page": "108427", "journal-title": "Clin Immunol", "key": "4778_CR48", "unstructured": "Yuki, K., Fujiogi, M. & Koutsogiannaki, S. COVID-19 pathophysiology: A review. Clin Immunol 215, 108427 (2020).", "volume": "215", "year": "2020" }, { "DOI": "10.1038/s41598-019-39081-w", "author": "R Kowsar", "doi-asserted-by": "crossref", "first-page": "3189", "journal-title": "Sci. Rep.", "key": "4778_CR49", "unstructured": "Kowsar, R., Keshtegar, B. & Miyamoto, A. Understanding the hidden relations between pro- and anti-inflammatory cytokine genes in bovine oviduct epithelium using a multilayer response surface method. Sci. Rep. 9, 3189 (2019).", "volume": "9", "year": "2019" }, { "DOI": "10.5812/archcid.102938", "doi-asserted-by": "crossref", "key": "4778_CR50", "unstructured": "Asadi, L., Tabatabaei, R. S., Safinejad, H. & Mohammadi, M. New corona virus (COVID-19) management in pregnancy and childbirth. Arch. Clin. Infect. Dis. 15 (2020)." }, { "DOI": "10.1002/jcc.21334", "author": "O Trott", "doi-asserted-by": "publisher", "first-page": "455", "journal-title": "J. Comput. Chem.", "key": "4778_CR51", "unstructured": "Trott, O. & Olson, A. J. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455–461. https://doi.org/10.1002/jcc.21334 (2010).", "volume": "31", "year": "2010" }, { "DOI": "10.2174/1389557516666160609080157", "author": "A Barzegar", "doi-asserted-by": "crossref", "first-page": "633", "journal-title": "Mini Rev. Med. Chem.", "key": "4778_CR52", "unstructured": "Barzegar, A., Naghizadeh, E., Zakariazadeh, M. & Azamat, J. Molecular dynamics simulation study of the HIV-1 protease inhibit ion using fullerene and new fullerene derivatives of carbon nanostructures. Mini Rev. Med. Chem. 17, 633–647 (2017).", "volume": "17", "year": "2017" }, { "DOI": "10.1371/journal.pcbi.1004586", "author": "PA Ravindranath", "doi-asserted-by": "crossref", "first-page": "e1004586", "journal-title": "PLoS Comput. Biol.", "key": "4778_CR53", "unstructured": "Ravindranath, P. A., Forli, S., Goodsell, D. S., Olson, A. J. & Sanner, M. F. AutoDockFR: Advances in protein-ligand docking with explicitly specified binding site flexibility. PLoS Comput. Biol. 11, e1004586 (2015).", "volume": "11", "year": "2015" }, { "DOI": "10.1021/acscentsci.1c00039", "author": "C-H Zhang", "doi-asserted-by": "crossref", "first-page": "467", "journal-title": "ACS Cent. Sci", "key": "4778_CR54", "unstructured": "Zhang, C.-H. et al. Potent noncovalent inhibitors of the main protease of SARS-CoV-2 from molecular sculpting of the drug perampanel guided by free energy perturbation calculations. ACS Cent. Sci 7, 467–475 (2021).", "volume": "7", "year": "2021" }, { "DOI": "10.1016/j.jmb.2015.09.014", "author": "GCP van Zundert", "doi-asserted-by": "crossref", "first-page": "720", "journal-title": "J. Mol. Biol.", "key": "4778_CR55", "unstructured": "van Zundert, G. C. P. et al. The HADDOCK2.2 web server: User-friendly integrative modeling of biomolecular complexes. J. Mol. Biol. 428, 720–725 (2016).", "volume": "428", "year": "2016" }, { "DOI": "10.1021/ci500020m", "author": "R Kumari", "doi-asserted-by": "crossref", "first-page": "1951", "journal-title": "J. Chem. Inf. Model.", "key": "4778_CR56", "unstructured": "Kumari, R., Kumar, R. & Lynn, A. g_mmpbsa—A GROMACS tool for high-throughput MM-PBSA calculations. J. Chem. Inf. Model. 54, 1951–1962 (2014).", "volume": "54", "year": "2014" }, { "DOI": "10.1073/pnas.181342398", "author": "NA Baker", "doi-asserted-by": "crossref", "first-page": "10037", "journal-title": "Proc. Natl. Acad. Sci.", "key": "4778_CR57", "unstructured": "Baker, N. A., Sept, D., Joseph, S., Holst, M. J. & McCammon, J. A. Electrostatics of nanosystems: Application to microtubules and the ribosome. Proc. Natl. Acad. Sci. 98, 10037–10041 (2001).", "volume": "98", "year": "2001" }, { "DOI": "10.1021/ct700200b", "author": "B Hess", "doi-asserted-by": "crossref", "first-page": "116", "journal-title": "J. Chem. Theory Comput.", "key": "4778_CR58", "unstructured": "Hess, B. P-LINCS: A parallel linear constraint solver for molecular simulation. J. Chem. Theory Comput. 4, 116–122 (2008).", "volume": "4", "year": "2008" }, { "DOI": "10.1016/j.softx.2015.06.001", "author": "MJ Abraham", "doi-asserted-by": "crossref", "first-page": "19", "journal-title": "SoftwareX", "key": "4778_CR59", "unstructured": "Abraham, M. J. et al. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1, 19–25 (2015).", "volume": "1", "year": "2015" }, { "DOI": "10.1021/ct900549r", "author": "P Bjelkmar", "doi-asserted-by": "crossref", "first-page": "459", "journal-title": "J. Chem. Theory Comput.", "key": "4778_CR60", "unstructured": "Bjelkmar, P., Larsson, P., Cuendet, M. A., Hess, B. & Lindahl, E. Implementation of the CHARMM Force Field in GROMACS: Analysis of protein stability effects from correction maps, virtual interaction sites, and water models. J. Chem. Theory Comput. 6, 459–466 (2010).", "volume": "6", "year": "2010" }, { "DOI": "10.1002/jcc.21816", "author": "V Zoete", "doi-asserted-by": "crossref", "first-page": "2359", "journal-title": "J. Comput. Chem.", "key": "4778_CR61", "unstructured": "Zoete, V., Cuendet, M. A., Grosdidier, A. & Michielin, O. SwissParam: A fast force field generation tool for small organic molecules. J. Comput. Chem. 32, 2359–2368 (2011).", "volume": "32", "year": "2011" }, { "DOI": "10.1002/jcc.21287", "author": "BR Brooks", "doi-asserted-by": "crossref", "first-page": "1545", "journal-title": "J. Comput. Chem.", "key": "4778_CR62", "unstructured": "Brooks, B. R. et al. CHARMM: The biomolecular simulation program. J. Comput. Chem. 30, 1545–1614 (2009).", "volume": "30", "year": "2009" }, { "DOI": "10.1021/acs.jctc.5b00935", "author": "J Lee", "doi-asserted-by": "crossref", "first-page": "405", "journal-title": "J. Chem. Theory Comput.", "key": "4778_CR63", "unstructured": "Lee, J. et al. CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM simulations using the CHARMM36 additive force field. J. Chem. Theory Comput. 12, 405–413 (2016).", "volume": "12", "year": "2016" }, { "DOI": "10.1093/bioinformatics/bts310", "author": "A Volkamer", "doi-asserted-by": "crossref", "first-page": "2074", "journal-title": "Bioinformatics", "key": "4778_CR64", "unstructured": "Volkamer, A., Kuhn, D., Rippmann, F. & Rarey, M. DoGSiteScorer: A web server for automatic binding site prediction, analysis and druggability assessment. Bioinformatics 28, 2074–2075 (2012).", "volume": "28", "year": "2012" }, { "DOI": "10.1093/nar/gkx333", "author": "R Fährrolfes", "doi-asserted-by": "crossref", "first-page": "W337", "journal-title": "Nucleic Acids Res.", "key": "4778_CR65", "unstructured": "Fährrolfes, R. et al. ProteinsPlus: A web portal for structure analysis of macromolecules. Nucleic Acids Res. 45, W337-w343 (2017).", "volume": "45", "year": "2017" }, { "DOI": "10.1038/nrd892", "author": "AL Hopkins", "doi-asserted-by": "crossref", "first-page": "727", "journal-title": "Nat. Rev. Drug Discov.", "key": "4778_CR66", "unstructured": "Hopkins, A. L. & Groom, C. R. The druggable genome. Nat. Rev. Drug Discov. 1, 727–730 (2002).", "volume": "1", "year": "2002" }, { "DOI": "10.1021/ci800324m", "author": "TA Halgren", "doi-asserted-by": "crossref", "first-page": "377", "journal-title": "J. Chem. Inf. Model.", "key": "4778_CR67", "unstructured": "Halgren, T. A. Identifying and characterizing binding sites and assessing druggability. J. Chem. Inf. Model. 49, 377–389 (2009).", "volume": "49", "year": "2009" }, { "DOI": "10.1016/j.drudis.2010.05.015", "author": "S Pérot", "doi-asserted-by": "crossref", "first-page": "656", "journal-title": "Drug Discov. Today", "key": "4778_CR68", "unstructured": "Pérot, S., Sperandio, O., Miteva, M. A., Camproux, A. C. & Villoutreix, B. O. Druggable pockets and binding site centric chemical space: A paradigm shift in drug discovery. Drug Discov. Today 15, 656–667 (2010).", "volume": "15", "year": "2010" }, { "DOI": "10.1002/prot.340230412", "author": "D Frishman", "doi-asserted-by": "crossref", "first-page": "566", "journal-title": "Proteins", "key": "4778_CR69", "unstructured": "Frishman, D. & Argos, P. Knowledge-based protein secondary structure assignment. Proteins 23, 566–579 (1995).", "volume": "23", "year": "1995" }, { "DOI": "10.1021/ci025515j", "author": "IV Tetko", "doi-asserted-by": "crossref", "first-page": "1136", "journal-title": "J. Chem. Inform. Comput. Sci.", "key": "4778_CR70", "unstructured": "Tetko, I. V. & Tanchuk, V. Y. Application of associative neural networks for prediction of lipophilicity in ALOGPS 2.1 program. J. Chem. Inform. Comput. Sci. 42, 1136–1145 (2002).", "volume": "42", "year": "2002" }, { "DOI": "10.1093/protein/8.2.127", "author": "AC Wallace", "doi-asserted-by": "crossref", "first-page": "127", "journal-title": "Protein Eng.", "key": "4778_CR71", "unstructured": "Wallace, A. C., Laskowski, R. A. & Thornton, J. M. LIGPLOT: A program to generate schematic diagrams of protein-ligand interactions. Protein Eng. 8, 127–134 (1995).", "volume": "8", "year": "1995" }, { "DOI": "10.1038/s41577-020-0348-8", "author": "EP Scully", "doi-asserted-by": "crossref", "first-page": "442", "journal-title": "Nat. Rev. Immunol.", "key": "4778_CR72", "unstructured": "Scully, E. P., Haverfield, J., Ursin, R. L., Tannenbaum, C. & Klein, S. L. Considering how biological sex impacts immune responses and COVID-19 outcomes. Nat. Rev. Immunol. 20, 442–447 (2020).", "volume": "20", "year": "2020" }, { "DOI": "10.1038/nri.2016.90", "author": "SL Klein", "doi-asserted-by": "crossref", "first-page": "626", "journal-title": "Nat. Rev. Immunol.", "key": "4778_CR73", "unstructured": "Klein, S. L. & Flanagan, K. L. Sex differences in immune responses. Nat. Rev. Immunol. 16, 626–638 (2016).", "volume": "16", "year": "2016" }, { "author": "AJ Li", "first-page": "102116", "journal-title": "Stem Cell Res.", "key": "4778_CR74", "unstructured": "Li, A. J. & Li, X. Sex-dependent immune response and lethality of COVID-19. Stem Cell Res. 50, 102116 (2020).", "volume": "50", "year": "2020" }, { "DOI": "10.1101/2020.07.29.227249", "doi-asserted-by": "crossref", "key": "4778_CR75", "unstructured": "Aguilar-Pineda, J. A. et al. Structural and functional analysis of female sex hormones against SARS-Cov2 cell entry. bioRxiv (2020)." }, { "DOI": "10.1016/S0140-6736(20)30317-2", "author": "CD Russell", "doi-asserted-by": "crossref", "first-page": "473", "journal-title": "Lancet", "key": "4778_CR76", "unstructured": "Russell, C. D., Millar, J. E. & Baillie, J. K. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet 395, 473–475 (2020).", "volume": "395", "year": "2020" }, { "DOI": "10.1002/jmv.26165", "author": "L Kolilekas", "doi-asserted-by": "crossref", "first-page": "2866", "journal-title": "J. Med. Virol.", "key": "4778_CR77", "unstructured": "Kolilekas, L. et al. Can steroids reverse the severe COVID-19 induced “cytokine storm”?. J. Med. Virol. 92, 2866–2869 (2020).", "volume": "92", "year": "2020" }, { "author": "C So", "first-page": "e00596", "journal-title": "Respirol. Case Rep.", "key": "4778_CR78", "unstructured": "So, C., Ro, S., Murakami, M., Imai, R. & Jinta, T. High-dose, short-term corticosteroids for ARDS caused by COVID-19: A case series. Respirol. Case Rep. 8, e00596 (2020).", "volume": "8", "year": "2020" }, { "key": "4778_CR79", "unstructured": "The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi 41, 145–151 (2020)." }, { "author": "S Zhao", "first-page": "1", "journal-title": "Infect. Control Hosp. Epidemiol.", "key": "4778_CR80", "unstructured": "Zhao, S. et al. The time-varying serial interval of the coronavirus disease (COVID-19) and its gender-specific difference: A data-driven analysis using public surveillance data in Hong Kong and Shenzhen, China from January 10 to February 15, 2020. Infect. Control Hosp. Epidemiol. 10, 1–8 (2020).", "volume": "10", "year": "2020" }, { "DOI": "10.1111/liv.13303", "author": "A Magri", "doi-asserted-by": "crossref", "first-page": "669", "journal-title": "Liver Int.", "key": "4778_CR81", "unstructured": "Magri, A. et al. 17, β-estradiol inhibits hepatitis C virus mainly by interference with the release phase of its life cycle. Liver Int. 37, 669–677 (2017).", "volume": "37", "year": "2017" } ], "reference-count": 81, "references-count": 81, "relation": {}, "resource": { "primary": { "URL": "https://www.nature.com/articles/s41598-022-04778-y" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [ "Multidisciplinary" ], "subtitle": [], "title": "The impact of calcitriol and estradiol on the SARS-CoV-2 biological activity: a molecular modeling approach", "type": "journal-article", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "volume": "12" }

Please send us corrections, updates, or comments. c19early involves the extraction of 200,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. IMA and WCH provide treatment protocols.

Submit

Post

@CovidAnalysis

FAQ

Public domain CC0 1.0